Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/56485
Title: Pharmacological treatment of COVID-19: an opinion paper.
Authors: 
Keywords: 
Mesh: 
Issue Date: 11-Dec-2021
Citation: Rev Esp Quimioter.2022;(35)2:115-130
Abstract: The precocity and efficacy of the vaccines developed so far against COVID-19 has been the most significant and saving advance against the pandemic. The development of vaccines has not prevented, during the whole period of the pandemic, the constant search for therapeutic medicines, both among existing drugs with different indications and in the development of new drugs. The Scientific Committee of the COVID-19 of the Illustrious College of Physicians of Madrid wanted to offer an early, simplified and critical approach to these new drugs, to new developments in immunotherapy and to what has been learned from the immune response modulators already known and which have proven effective against the virus, in order to help understand the current situation.
PMID: 34894208
URI: https://hdl.handle.net/20.500.12530/56485
Rights: openAccess
Appears in Collections:Centros de Atención Primaria > Artículos

Files in This Item:
File SizeFormat 
PMC8972693.pdf257.93 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.